MedTrace Logo

Effects of Theobromine and Caffeine on Mood, Cognition and Blood Pressure

NCT01288547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-02-23

No results posted yet for this study

Summary

The purpose of this study was to measure potential mood, cognition and blood pressure effects of theobromine and caffeine in healthy women

Conditions

  • Mood

Interventions

DIETARY_SUPPLEMENT

theobromine

700 mg theobromine in gelatin capsules given one time only

DIETARY_SUPPLEMENT

Caffeine

120 mg caffeine in capsules given one time only

DIETARY_SUPPLEMENT

caffeine + theobromine

120 mg caffeine and 700 mg theobromine in capsules given one time only

DIETARY_SUPPLEMENT

placebo

cellulose in capsules given one time only

Sponsors & Collaborators

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Yvonne Zebregs · Unilever R&D

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-06-30
Completion
2008-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01288547 on ClinicalTrials.gov